Quantum Genesis AI Corp.

03/19/2026 | Press release | Distributed by Public on 03/19/2026 13:15

Quarterly Report for Quarter Ending January 31, 2026 (Form 10-Q)

Management's Discussion and Analysis of Financial Conditions and Results of Operations.

FORWARD-LOOKING STATEMENTS

The following discussion may contain forward-looking statements regarding the Company, its business prospects and its results of operations that are subject to certain risks and uncertainties posed by many factors and events that could cause the Company's actual business, prospects and results of operations to differ materially from those that may be anticipated by such forward-looking statements. These forward-looking statements reflect our view only as of the date of this report. The Company cannot guarantee future results, levels of activity, performance, or achievement. The Company does not undertake any obligation to update or correct any forward-looking statements.

Results of Operations for the three and six months ended January 31, 2026 and 2025

Revenues

We earned no revenues for three and six months ended January 31, 2026 or 2025.

Operating Expenses

We incurred $1,382 in operating expenses for the three months ended January 31, 2026, as compared with $24,534 in the three months ended January 31, 2025. The decrease in operating expenses is the result of decreased professional fees during the three months ended January 31, 2026. We expect our operating expenses will increase in future years as a result of the costs associated with the increased operating activity under our business model.

We incurred $40,578 in operating expenses for the six months ended January 31, 2026, as compared with $85,468 in the six months ended January 31, 2025. The decrease in operating expenses is the result of decreased professional fees during the six months ended January 31, 2026. We expect our operating expenses will increase in future years as a result of the costs associated with the increased operating activity under our business model.

Other Income/Expenses

We had other expenses of $4,328,275 for the three months ended January 31, 2026, compared to other expenses of $29,806 for the three months ended January 31, 2025. The increase in other expenses was the result of a loss on settlement of debt that occurred during the three months ended January 31, 2026.

We had other expenses of $4,338,947 for the six months ended January 31, 2026, compared to other expenses of $3,861 for the six months ended January 31, 2025. The increase in other expenses was the result of a loss on settlement of debt that occurred during the six months ended January 31, 2026.

Net Loss

We recorded a net loss of $4,329,657 for the three months ended January 31, 2026, compared to a net loss $29,806 for the three months ended January 31, 2025. The decrease in net loss was associated with the factors discussed above.

We recorded a net loss of $4,379,525 for the six months ended January 31, 2026, compared to a net loss $89,329 for the six months ended January 31, 2025. The decrease in net loss was associated with the factors discussed above.

14

Going Concern

The accompanying financial statements have been prepared in US dollars and in accordance with accounting principles generally accepted in the United States ("GAAP") on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During the six months ended January 31, 2026 the Company incurred net losses of $4,379,525, accumulated deficits of $10,016,092, and used cash in operations in the amount of $43,810. These conditions raise substantial doubt about the Company's ability to continue as a going concern.

We are entirely dependent on our ability to attract and receive funding from either the sale of securities or outside sources such as private investment or a strategic partner. We currently have no firm agreements or arrangements with respect to any such financing and there can be no assurance that any needed funds will be available to us on acceptable terms or at all. The inability to obtain sufficient funding of our operations in the future will restrict our ability to grow and reduce our ability to continue to conduct business operations. Our failure to raise additional funds will adversely affect our business, and may require us to suspend our operations, which in turn may result in a loss to the purchasers of our common stock. If we are unable to obtain necessary financing, we will likely be required to curtail our development plans. Any additional equity financing may involve substantial dilution to our then existing stockholders.

Liquidity and Capital Resources

Our financing objective is to maintain financial flexibility to meet the material, equipment and personnel needs to support our project commitments, and pursue our expansion and diversification objectives.

As of January 31, 2026, we had total current assets of $59 and total current liabilities of $418,401. We had a working capital deficit of $418,342 as of January 31, 2026.

Net cash used by operating activities was $43,810 for the six months ended January 31, 2026, as compared with $49,575 cash used for the six months ended January 31, 2025. Our negative operating cash flow for both periods was our net losses, as adjusted to reconcile net loss to net cash provided by operating activities.

Financing activities provided $43,285 in cash for the six months ended January 31, 2026, as compared with $51,329 for the six months ended January 31, 2025.The decrease in cash provided by financing activities was the result of a decrease in proceeds provided through the issuance of notes during the six months ended January 31, 2026

Quantum Genesis AI Corp. published this content on March 19, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 19, 2026 at 19:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]